BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Struck A, Howard T, Chiorean EG, Clarke JM, Riffenburgh R, Cardenes HR. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol. 2009;100:144-148. [PMID: 19544358 DOI: 10.1002/jso.21319] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Suh CH, Tirumani SH, Shinagare AB, Kim KW, Rosenthal MH, Ramaiya NH, Baheti AD. Diagnosis and management of duodenal adenocarcinomas: a comprehensive review for the radiologist. Abdom Imaging 2015;40:1110-20. [DOI: 10.1007/s00261-014-0309-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Jiang S, Zhao R, Li Y, Han X, Liu Z, Ge W, Dong Y, Han W. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database. Sci Rep 2018;8:7940. [PMID: 29786691 DOI: 10.1038/s41598-018-26145-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
3 Cloyd JM, George E, Visser BC. Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World J Gastrointest Surg 2016; 8(3): 212-221 [PMID: 27022448 DOI: 10.4240/wjgs.v8.i3.212] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
4 Li D, Si X, Wan T, Zhou Y. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review. Asian J Surg 2019;42:46-52. [PMID: 29802028 DOI: 10.1016/j.asjsur.2018.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Hirashita T, Ohta M, Tada K, Saga K, Takayama H, Endo Y, Uchida H, Iwashita Y, Inomata M. Prognostic factors of non-ampullary duodenal adenocarcinoma. Jpn J Clin Oncol 2018;48:743-7. [PMID: 29931295 DOI: 10.1093/jjco/hyy086] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Golhar A, Mangla V, Mehrotra S, Lalwani S, Mehta N, Nundy S. Limited distal duodenal resection: Surgical approach and outcomes. A case series. Ann Med Surg (Lond) 2018;30:36-41. [PMID: 30013770 DOI: 10.1016/j.amsu.2018.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kato Y, Takahashi S, Kinoshita T, Shibasaki H, Gotohda N, Konishi M. Surgical Procedure Depending on the Depth of Tumor Invasion in the Duodenal Cancer. Japanese Journal of Clinical Oncology 2014;44:224-31. [DOI: 10.1093/jjco/hyt213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cloyd JM, Norton JA, Visser BC, Poultsides GA. Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases. Ann Surg Oncol. 2015;22:573-580. [PMID: 25160736 DOI: 10.1245/s10434-014-4020-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
9 Augustin T, Moslim MA, Cengiz TB, El-Hayek K, Simon R, Bhatt A, Tang A, Burke CA, Matthew Walsh R. Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer. J Surg Oncol 2020;122:1132-44. [PMID: 33124067 DOI: 10.1002/jso.26131] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Wang Z, Ding Z, Huang S, Zhong S. Experience in clinical diagnosis and treatment of duodenal tumors. Mol Clin Oncol 2016;5:731-9. [PMID: 28105351 DOI: 10.3892/mco.2016.1061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19:1928-1935. [PMID: 22167476 DOI: 10.1245/s10434-011-2168-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
12 Solaini L, Jamieson NB, Metcalfe M, Abu Hilal M, Soonawalla Z, Davidson BR, McKay C, Kocher HM; UK Duodenal Cancer Study Group. Outcome after surgical resection for duodenal adenocarcinoma in the UK. Br J Surg. 2015;102:676-681. [PMID: 25776995 DOI: 10.1002/bjs.9791] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
13 Nortunen M, Parkkila S, Saarnio J, Huhta H, Karttunen TJ. Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma. J Histochem Cytochem 2021;69:677-90. [PMID: 34636283 DOI: 10.1369/00221554211050133] [Reference Citation Analysis]
14 Ushiku T, Arnason T, Fukayama M, Lauwers GY. Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol. 2014;38:1484-1493. [PMID: 25310836 DOI: 10.1097/pas.0000000000000278] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 4.9] [Reference Citation Analysis]
15 Wang N, Bu Q, Liu Q, Yang J, He H, Liu J, Ren X, Lyu J. Effect of marital status on duodenal adenocarcinoma survival: A Surveillance Epidemiology and End Results population analysis. Oncol Lett 2019;18:1904-14. [PMID: 31423260 DOI: 10.3892/ol.2019.10475] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Stilidi IS, Nered SN, Nikulin MP, Egenov OA, Petrosyan AP, Arkhiri PP. Distal duodenectomy: a new option of surgical treatment for duodenal tumors. Khir Z im N I Pirogova 2019. [DOI: 10.17116/hirurgia20190915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Zhang S, Cui Y, Zhong B, Xiao W, Gong X, Chao K, Chen M. Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China. Int J Colorectal Dis. 2011;26:219-226. [PMID: 20931208 DOI: 10.1007/s00384-010-1063-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
18 Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Lombardo KM, Haddock MG, Que FG. Neoadjuvant treatment of duodenal adenocarcinoma: a rescue strategy. J Gastrointest Surg. 2012;16:320-324. [PMID: 21956430 DOI: 10.1007/s11605-011-1667-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
19 Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies? Ann Surg Oncol. 2013;20:430-439. [PMID: 22956064 DOI: 10.1245/s10434-012-2603-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
20 Dave A, Wiseman JT, Cloyd JM. Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies. Expert Opinion on Orphan Drugs 2019;7:463-72. [DOI: 10.1080/21678707.2019.1684257] [Reference Citation Analysis]
21 Wilhelm A, Galata C, Beutner U, Schmied BM, Warschkow R, Steffen T, Brunner W, Post S, Marti L. Duodenal localization is a negative predictor of survival after small bowel adenocarcinoma resection: A population-based, propensity score-matched analysis. J Surg Oncol 2018;117:397-408. [DOI: 10.1002/jso.24877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
22 Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Reid-Lombardo KM, Harmsen WS, Que FG. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg. 2012;16:682-691. [PMID: 22350721 DOI: 10.1007/s11605-011-1808-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
23 Lancellotta V, Russo G, Lupattelli M, Iacco M, Perrucci E, Zucchetti C, Falcinelli L, Aristei C. Helical tomotherapy for duodenal adenocarcinoma in an elderly patient: A case report. World J Gastrointest Oncol 2017; 9(2): 94-97 [PMID: 28255431 DOI: 10.4251/wjgo.v9.i2.94] [Reference Citation Analysis]
24 Xia H, Yuan XM, Jiang KT. Bile duct metastasis of duodenal bulb carcinoma misdiagnosed as postoperative cholangitis: A case report. Shijie Huaren Xiaohua Zazhi 2016; 24(16): 2597-2600 [DOI: 10.11569/wcjd.v24.i16.2597] [Reference Citation Analysis]
25 Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol. 2013;44:2792-2798. [PMID: 24139211 DOI: 10.1016/j.humpath.2013.07.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
26 Calatayud D, Dehlendorff C, Boisen MK, Hasselby JP, Schultz NA, Werner J, Immervoll H, Molven A, Hansen CP, Johansen JS. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. Biomark Res. 2017;5:8. [PMID: 28239461 DOI: 10.1186/s40364-017-0087-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
27 Meijer LL, Alberga AJ, de Bakker JK, van der Vliet HJ, Le Large TYS, van Grieken NCT, de Vries R, Daams F, Zonderhuis BM, Kazemier G. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018;25:2681-2692. [PMID: 29946997 DOI: 10.1245/s10434-018-6567-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
28 Jang B, Park HJ, Kim K, Jang J, Kim SW, Oh D, Chie EK. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution. World J Surg 2018;42:3294-301. [DOI: 10.1007/s00268-018-4692-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Téoule P, Distler M, Niedergethmann M, Gaiser T, Rückert F, Grützmann R, Wilhelm TJ. Retrospective analysis of prognostic factors in patients with duodenal adenocarcinoma. Eur Surg 2016;48:228-34. [DOI: 10.1007/s10353-015-0374-0] [Reference Citation Analysis]
30 Kim MJ, Choi SB, Han HJ, Park PJ, Kim WB, Song TJ, Suh SO, Choi SY. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma. Kaohsiung J Med Sci. 2014;30:254-259. [PMID: 24751389 DOI: 10.1016/j.kjms.2013.12.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
31 Yang QY, Tang CT, Huang YF, Shao DT, Shu X. Development and validation of a nomogram for primary duodenal carcinoma: a multicenter, population-based study. Future Oncol 2022. [PMID: 35114801 DOI: 10.2217/fon-2021-0622] [Reference Citation Analysis]
32 Kanehira M, Futagawa Y, Furukawa K, Shiba H, Uwagawa T, Yanaga K. Radical resection of a primary unresectable duodenal cancer after chemotherapy using S-1 and cisplatin: report of a case. Surg Case Rep 2017;3:34. [PMID: 28224561 DOI: 10.1186/s40792-017-0304-4] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Burasakarn P, Higuchi R, Nunobe S, Kanaji S, Eguchi H, Okada KI, Fujii T, Nagakawa Y, Kanetaka K, Yamashita H, Yamada S, Kuroda S, Aoyama T, Akahori T, Nakagawa K, Yamamoto M, Yamaue H, Sho M, Kodera Y; Japan Duodenal Cancer Guideline Committee. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis. Int J Clin Oncol 2021;26:450-60. [PMID: 33386555 DOI: 10.1007/s10147-020-01840-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Xue Y, Vanoli A, Balci S, Reid MM, Saka B, Bagci P, Memis B, Choi H, Ohike N, Tajiri T, Muraki T, Quigley B, El-rayes BF, Shaib W, Kooby D, Sarmiento J, Maithel SK, Knight JH, Goodman M, Krasinskas AM, Adsay V. Non-ampullary–duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas. Mod Pathol 2017;30:255-66. [DOI: 10.1038/modpathol.2016.174] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
35 Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, Fraker DL, Drebin JA, Karakousis GC, Roses RE. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis. Cancer. 2016;122:693-701. [PMID: 26717303 DOI: 10.1002/cncr.29840] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
36 Oyasiji T, Alosi J, Tan W, Wilfong C, Wilkinson N. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes. The American Surgeon 2015;81:1125-33. [DOI: 10.1177/000313481508101124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
37 Shiba S, Miki A, Ohzawa H, Teratani T, Sakuma Y, Lefor AK, Kitayama J, Sata N. Functional Expression of Mucin1 in Human Duodenal Adenocarcinoma. Journal of Surgical Research 2019;238:79-89. [DOI: 10.1016/j.jss.2019.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Jabbour SK, Mulvihill D. Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol. 2014;24:85-93. [PMID: 24635865 DOI: 10.1016/j.semradonc.2013.11.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]